Naoki Kishimoto

6PUBLICATIONS
49CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Biologically active moleculesGenetic immunologyCheminformatics and quantitative structure-activity relationshipsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 13, 2025
Structural basis of the hepatitis B virus X protein in complex with DDB1.

Hiroki Tanaka, Joao Diogo Dias, Basile Jay

|Jan 20, 2025
An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.

Nobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi

|Jul 12, 2023
GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants.

Manabu Aoki, Hiromi Aoki-Ogata, Haydar Bulut

|Feb 25, 2023
Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.

Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi

|Dec 20, 2022
Nanoparticles of folic acid-methyl-β-cyclodextrin (FA-MβCD)/adamantane-albumin exhibit enhanced antitumor activity compared with FA-MβCD alone.

Aiko Sakai, Yuki Yamashita, Shogo Misumi

|Jan 29, 2021
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication.

Shin-Ichiro Hattori, Nobuyo Higashi-Kuwata, Hironori Hayashi

Pageof 1

Frequent Collaborators

5 joint publications

Shogo Misumi

4 joint publications

Shin-Ichiro Hattori

4 joint publications

Nobuyo Higashi-Kuwata

4 joint publications

Haydar Bulut